NRBO · Categories · Form 3

NRBO - SEC Form 3 initial insider statements

NeuroBo Pharmaceuticals Inc. (NRBO) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for NRBO

• 944d
  SEC Form 3 filed by new insider Tursi James Patrick

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 947d
  SEC Form 3 filed by new insider Woodworth Marshall H

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1119d
  SEC Form 3 filed by new insider Glickman Mark A

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1232d
  SEC Form 3 filed by new insider Hooker Joseph

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1289d
  SEC Form 3: New insider Goldman Sachs Group Inc claimed ownership of 1,220,502 shares

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1582d
  SEC Form 3 filed by new insider Strickland D Gordon

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1672d
  SEC Form 3 filed by new insider Price Ben Gil

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1780d
  SEC Form 3 filed by Kim Hyung Heon

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1780d
  SEC Form 3 filed by KOVEN ANDREW I

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)

Other NRBO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends